相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum YKL-40 and IL 17 in Psoriasis: Reliability as prognostic markers for disease severity and responsiveness to treatment
Shrook A. Khashaba et al.
DERMATOLOGIC THERAPY (2021)
Angiotensin-converting enzyme and subclinical atherosclerosis in psoriasis: Is there any association? A case-control study
Fahimeh Abdollahimajd et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Association of Pharmacological Biomarkers with Treatment Response and Longterm Disability in Patients with Psoriatic Arthritis: Results from OUTPASS
Meghna Jani et al.
JOURNAL OF RHEUMATOLOGY (2020)
Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis
Guilherme Gomes Teixeira et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2020)
Emerging molecular biomarkers for predicting therapy response in psoriatic arthritis: A review of literature
Juliette Pouw et al.
CLINICAL IMMUNOLOGY (2020)
High Levels of Platelet-Lymphocyte Complexes in Patients with Psoriasis Are Associated with a Better Response to Anti-TNF-α Therapy
Maria Teresa Sanz-Martinez et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Correlation of serum protein biomarkers with disease activity in psoriatic arthritis
T. A. Boyd et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Serum MicroRNA Signature as a Diagnostic and Therapeutic Marker in Patients with Psoriatic Arthritis
Sarah M. Wade et al.
JOURNAL OF RHEUMATOLOGY (2020)
Psoriasis-Like Inflammation Induced Renal Dysfunction through the TLR/NF-κB Signal Pathway
Fang Ren et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Neutrophil/platelet to lymphocyte ratio in monitoring of response to TNF-α inhibitors in psoriatic patients
Niloofar Najar Nobari et al.
DERMATOLOGIC THERAPY (2020)
High-sensitivity C-reactive protein as a biomarker in detecting subclinical atherosclerosis in psoriasis
Nasim Niknezhad et al.
DERMATOLOGIC THERAPY (2020)
Pathway to biomarker discovery in psoriatic arthritis
Vinod Chandran
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Assessment of serum biomarkers in patients with plaque psoriasis on secukinumab
Akimichi Morita et al.
JOURNAL OF DERMATOLOGY (2020)
The Inflammasome Signaling Proteins ASC and IL-18 as Biomarkers of Psoriasis
Mahtab Forouzandeh et al.
FRONTIERS IN PHARMACOLOGY (2020)
Thymus and activation-regulated chemokine (TARC) in patients with psoriasis: Increased serum TARC levels in patients with generalized pustular psoriasis
Yurika Kawasaki et al.
JOURNAL OF DERMATOLOGY (2020)
Methotrexate and Adalimumab Decrease the Serum Levels of Cardiovascular Disease Biomarkers (VCAM-1 and E-Selectin) in Plaque Psoriasis
Natalia Zdanowska et al.
MEDICINA-LITHUANIA (2020)
Applying precision medicine to unmet clinical needs in psoriatic disease
Deepak R. Jadon et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Interleukin-18, interleukin-20, and matrix metalloproteinases (MMP-1, MMP-3) as markers of psoriatic arthritis disease severity and their correlations with biomarkers of inflammation and turnover of joint cartilage
Michal Waszczykowski et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2020)
Hepascore predicts liver outcomes and all-cause mortality in long-term methotrexate users: A retrospective cohort study
Zhengyi Wang et al.
JGH OPEN (2020)
A set of serum markers detecting systemic inflammation in psoriatic skin, entheseal, and joint disease in the absence of C-reactive protein and its link to clinical disease manifestations
Maria Sokolova et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Can serum level of N-terminal pro B-type natriuretic peptide be used in patients with psoriasis as a predictor of cardiovascular disease?
Mohammad Shahidi-Dadras et al.
DERMATOLOGIC THERAPY (2019)
Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition
Jose U. Scher et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Proinflammatory and anti-inflammatory cytokine profiles in psoriasis: use as laboratory biomarkers and disease predictors
Camila Cataldi et al.
INFLAMMATION RESEARCH (2019)
Biomarkers of Inflammation in Obesity-Psoriatic Patients
Carmen Rodriguez-Cerdeira et al.
MEDIATORS OF INFLAMMATION (2019)
Serum levels of YKL-40 are increased in patients with psoriasis: a meta-analysis
Yi Kong et al.
POSTGRADUATE MEDICINE (2019)
Association of Serum Lipocalin-2 Concentrations with Psoriasis and Psoriatic Arthritis: An Updated Meta-Analysis
Dingjian Wang et al.
DISEASE MARKERS (2019)
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis
Nick Dand et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis
Fan Bai et al.
ONCOTARGET (2018)
Serum levels of psoriasin (S100A7) and koebnerisin (S100A15) as potential markers of atherosclerosis in patients with psoriasis
S. M. Awad et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2018)
Alteration of serum thymus and activation-regulated chemokine level during biologic therapy for psoriasis: Possibility as a marker reflecting favorable response to anti-interleukin-17A agents
Takashi Shibuya et al.
JOURNAL OF DERMATOLOGY (2018)
Differentiating Psoriatic Arthritis From Psoriasis Without Psoriatic Arthritis Using Novel Serum Biomarkers
Daniela Cretu et al.
ARTHRITIS CARE & RESEARCH (2018)
The enhanced liver fibrosis (ELF) test in diagnosis and management of liver fibrosis
James W. Day et al.
BRITISH JOURNAL OF HOSPITAL MEDICINE (2018)
Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis An Observational Cohort Study
Alexander V. Sorokin et al.
CIRCULATION RESEARCH (2018)
Exploring the Psoriatic Arthritis Proteome in Search of Novel Biomarkers
Shalini M. Mahendran et al.
PROTEOMES (2018)
Lessons to be learned from serum biomarkers in psoriasis and IBD - the potential role in SpA
Maureen C. Turina et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Roles of microRNAs in psoriasis: Immunological functions and potential biomarkers
Qing Liu et al.
EXPERIMENTAL DERMATOLOGY (2017)
Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase
Naif O. Al-Harbi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?
Sirje Kaur et al.
MEDIATORS OF INFLAMMATION (2017)
Cardiometabolic Disorders in Psoriatic Disease
Curtis Sobchak et al.
CURRENT RHEUMATOLOGY REPORTS (2017)
Serum Leptin, Resistin, and Adiponectin Concentrations in Psoriasis: A Meta-Analysis of Observational Studies
Aikaterini Kyriakou et al.
DERMATOLOGY (2017)
Correlation between vascular endothelial growth factor and subclinical atherosclerosis in patients with psoriasis
Mohammad Shahidi-Dadras et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2016)
GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis
Aditya A. Joshi et al.
CIRCULATION RESEARCH (2016)
Biomarkers in psoriatic arthritis: a systematic literature review
Elena Generali et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
CXCL10 Is a Possible Biomarker for the Development of Psoriatic Arthritis Among Patients With Psoriasis
Fatima Abji et al.
Arthritis & Rheumatology (2016)
GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation
James D. Otvos et al.
CLINICAL CHEMISTRY (2015)
Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis
Muhammad Haroon et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases
Alessandro Antonelli et al.
AUTOIMMUNITY REVIEWS (2014)
Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study
C. L. Martyn-Simmons et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis
C. M. Maybury et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Increased serum leptin and resistin levels and increased carotid intima-media wall thickness in patients with psoriasis: Is psoriasis associated with atherosclerosis?
Reza M. Robati et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
The Use of Transient Elastography and FibroTest for Monitoring Hepatotoxicity in Patients Receiving Methotrexate for Psoriasis
Maeve Lynch et al.
JAMA DERMATOLOGY (2014)
Biomarkers in psoriasis and psoriatic arthritis
Federica Villanova et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Inflammation, Atherosclerosis, and Psoriasis
David Siegel et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
Assessment of methotrexate hepatotoxicity in psoriasis patients: a prospective evaluation of four serum fibrosis markers
J. Chladek et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Vitamin D Analog Calcipotriol Suppresses the Th17 Cytokine-Induced Proinflammatory S100 Alarmins Psoriasin (S100A7) and Koebnerisin (S100A15) in Psoriasis
Zuzana Hegyi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?
Dafna D. Gladman et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept
A. Kanelleas et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2011)
Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic
J. Barker et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
High-sensitivity C-reactive protein at different stages of atherosclerosis: results of the INVADE study
Carla Schulze Horn et al.
JOURNAL OF NEUROLOGY (2009)
β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin
Patrick A. M. Jansen et al.
PLOS ONE (2009)
C-reactive protein is elevated in obese patients with the metabolic syndrome
H Florez et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2006)
分享论文
